comprehensive -WSS

comprehensive

author：Wikipedia 2025-08-25 15:09:10 - browse：34238

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company amid a wave of consumer complaints about patients receiving incorrect medicines or being unable to get their prescriptions filled.

Elevance did not confirm Marchetti’s departure as the president of CarelonRx, but according to his Linkedin profile, he left the company in May.

Elevance, the second-largest commercial health insurer in the country by market share, uses its CarelonRx subsidiary to manage its pharmacy business. In online complaints, CarelonRx customers point toward January 1 as the date when issues with obtaining their prescriptions from the company began. The reported problems include safety issues like receiving other people’s medications or receiving medications they discontinued years ago.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Smaller biotechs seek to piggyback on weight loss drug boom

WSS

Focused ultrasound for uterine fibroids: an uphill battle

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Scientists successfully use ultrasound imaging to map brain activity

Readout LOUD podcast: Live from the 2023 STAT Summit

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Scientists successfully use ultrasound imaging to map brain activity

Wikipedia

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

entertainment

Affirmative action in medical school literally saved lives

Why a market frenzy over new weight loss drugs defies logic

Medicare proposal to cover medical devices draws a mixed reaction

Roivant's CEO is a star, but biotech's black hole persists

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Akili, maker of video game for ADHD, to be acquired for 34 million

At least 13 dead in Texas as scorching temps continue

Why a market frenzy over new weight loss drugs defies logic

Supreme Court strikes down use of affirmative action

How AI can help patients find reliable information about doctors

hotspot

Addiction doctors spar with methadone clinics over legislation

STAT Summit: Meghan O’Rourke on making chronic illness visible

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Smaller biotechs seek to piggyback on weight loss drug boom

Do more moles mean more problems? Not so, says new study

Akili, maker of video game for ADHD, to be acquired for 34 million

hotspot

leisure time

explore

knowledge